Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Lignende værker

• Association of early changes in (1)H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen
  af: Nelson, Sarah J., et al.
  Udgivet: (2017)
• Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM
  af: Essock-Burns, Emma, et al.
  Udgivet: (2012)
• Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme
  af: Li, Yan, et al.
  Udgivet: (2011)
• Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
  af: Wen, Qiuting, et al.
  Udgivet: (2014)
• Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor()()
  af: Autry, Adam, et al.
  Udgivet: (2017)